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Intrauterine growth restriction (IUGR) increases the risk of developing diabetes in later life, which indicates developmental programming of islets. IUGR fetuses with placental insufficiency develop hypoxemia, elevating epinephrine and norepinephrine (NE) concentrations throughout late gestation. To isolate the programming effects of chronically elevated catecholamines, NE was continuously infused into normally grown sheep fetuses for 7 days. High plasma NE concentrations suppress insulin, but after the NE infusion was terminated, persistent hypersecretion of insulin occurred. Our objective was to identify differential gene expression with RNA sequencing (RNAseq) in fetal islets after chronic adrenergic stimulation. After determining the NE-regulated genes, we identified the subset of differentially expressed genes that were common to both islets from NE fetuses and fetuses with IUGR to delineate the adrenergic-induced transcriptional responses. A portion of these genes were investigated in mouse insulinoma (Min6) cells chronically treated with epinephrine to better approximate the b-cell response. In islets from NE fetuses, RNAseq identified 321 differentially expressed genes that were overenriched for metabolic and hormone processes, and the subset of 96 differentially expressed genes common to IUGR islets were overenriched for protein digestion, vitamin metabolism, and cell replication pathways. Thirty-eight of the 96 NEregulated IUGR genes changed similarly between models with functional enrichment for proliferation. In Min6 cells, chronic epinephrine stimulation slowed proliferation and augmented insulin secretion after treatment. These data establish molecular mechanisms underlying persistent adrenergic stimulation in hyperfunctional fetal islets and identify a subset of genes dysregulated by catecholamines in IUGR islets that may represent programming of b-cell proliferation capacity. (Endocrinology 159: [3565] [3566] [3567] [3568] [3569] [3570] [3571] [3572] [3573] [3574] [3575] [3576] [3577] [3578] 2018) B abies born small for gestational age, defined as birth weight in the lower 10th percentile, have greater incidence of neonatal morbidity and mortality (1) . Pregnancies complicated by placental insufficiency (PI) are a prominent cause of intrauterine growth restriction (IUGR), leading to babies who are small for gestational age. Furthermore, longitudinal studies on infants born with a low birth weight show that they have an elevated risk of developing metabolic disease with age, which indicates that developmental adaptations to their in utero environment lead to the sequela of type 2 diabetes mellitus and permanent islet dysfunction (2) (3) (4) .
Human fetuses with IUGR develop in conditions of hypoxemia, hypoglycemia, elevated norepinephrine (NE), and low insulin concentrations (5) (6) (7) . Fetuses with severe IUGR demonstrate impaired glucose-stimulated insulin secretion (GSIS) and deficits in b-cell mass, implicating the pancreatic islet as a target for metabolic dysfunction (5, 6, 8) . A sheep model of PI created by maternal heat stress during midgestation results in IUGR (PI-IUGR) and reliably recapitulates several key conditions reported in human fetuses with IUGR, including fetal hypoglycemia and hypoxemia, lower basal plasma insulin concentrations, impaired GSIS, lower b-cell mass, and ontogenetic increases in the concentrations of catecholamines (9) (10) (11) (12) . However, the prevailing hypoxemic and hypoglycemic conditions and secondary effects in fetuses with PI and IUGR have not been fully elucidated in regard to persistent islet dysfunction.
Islets isolated from fetuses with PI-IUGR have greater fractional insulin secretion in vitro than islets isolated from control fetuses, indicating compensatory b-cell secretion (9, 13) . Compensatory b-cell insulin secretion persists after birth in lambs with PI-IUGR and in humans born small for gestational age. One-week-old lambs with PI-IUGR have greater GSIS compared with control lambs (14) . Similarly, infants born small for gestational age often present with hyperinsulinemic hypoglycemia within the first few hours of life up to 1 year, suggesting their insulin secretion is inappropriate for their insulin sensitivity (15) (16) (17) . Of these infants, those with the highest incidence of hyperinsulinemia were from pregnancies complicated by fetal stress, consistent with the PI-IUGR sheep model with elevated catecholamines (7, 13, 16) . Thus, b-cell adaptations develop in fetuses with IUGR with elevated NE, and these adaptations persist to influence insulin secretion in the neonate.
To determine the effects of sustained exposure to high plasma NE concentrations, we investigated insulin secretion in late gestation fetal sheep that were normally grown but intravenously infused with NE for 7 days (NE fetuses). The timing of the NE infusion is consistent with the period of maximal responsiveness of the adrenal chromaffin cells to hypoxia and when NE concentrations are highest in fetuses with PI-IUGR. In normal sheep fetuses, acute hypoxia stimulates NE secretion and increases plasma concentrations as early as 110 days' gestation (;70% of gestation) and progresses to sixfold at 135 days' gestation (;90%) (18, 19) . During the NE infusion, GSIS was suppressed, but after termination of the NE infusion, after NE concentrations fell, albeit not to control concentrations, GSIS increased (20) . The increase insulin secretion was shown to persist for 5 days in vivo and to be an intrinsic adaptation of islets, based on increased GSIS after isolation (21) . These results are congruent with inhibiting adrenergic receptor activity in the fetuses with PI-IUGR, where catecholamines are also chronically elevated. Acute treatment with adrenergic receptor antagonists resulted in greater GSIS in fetuses with PI-IUGR (22, 23) . Additionally, in the absence of high circulating catecholamines that was achieved with bilateral surgical ablation of the fetal adrenal medullae (demedullation) in fetuses with PI-IUGR, there was no observed hypersecretion of insulin (22) (23) (24) . Together, these findings indicate that chronically elevated catecholamines play a role in the development of persistent islet adaptations in fetal sheep that parallel human conditions (13) .
The objective of this study was to identify persistent adrenergic-regulated mRNA expression in islets isolated from fetal sheep after 7 days of NE infusion via highthroughput mRNA sequencing. We hypothesize that this unbiased approach to examining differential gene expression will reveal mechanisms that explain persistent hypersecretion of insulin and b-cell abnormalities in islets after fetal stress with hypercatecholaminemia. To isolate adrenergic-related effects in the PI-IUGR islet transcriptome, we performed subsequent bioinformatic comparisons of differentially expressed genes from islets of NE fetuses and from islets of fetuses with PI-IUGR reported previously (25) . This comparison identified a subset of genes that were differentially expressed in islets isolated from both NE fetuses and fetuses with PI-IUGR, representing targets of adrenergic regulation in PI-IUGR islet.
To investigate these genetic responses after chronic adrenergic stimulation, we evaluated the mouse insulinoma 6 (Min6) cell line that has GSIS responsiveness after culturing cells for 72 hours in stimulatory epinephrine concentrations. Proliferation genes that were adrenergic regulated in fetal sheep islets were also identified in Min6 cells cultured with epinephrine. These experiments begin to define adrenergic-regulated genes that are involved in programming potential defects in islets of fetuses with IUGR.
Material and Methods

Animal preparation
Columbia-Rambouillet crossbred ewes carrying singleton pregnancies were managed in compliance with the Institutional Animal Care and Use Committee at the University of Arizona. All animal procedures and in vivo experiments were reported previously (20) . Control fetuses received an intravenous infusion of diluent (0.3% ascorbic acid in 0.9% saline). NE fetuses received an intravenous infusion of NE (norepinephrine bitartrate; Bedford Laboratories, OH; 1 to 4 mg/min) for 7 days at preset rates for each day of treatment (day 1 at 1 mg/min, days 2 through 4 at 2 mg/min, and days 5 through 7 at 4 mg/min). The NE infusion increased plasma NE concentrations ninefold compared with vehicle-infused control fetuses (20) . On day 7 of treatment, the infusions were stopped ;6 hours before necropsy. Ewes and fetuses were euthanized and fetal pancreatic islets were isolated as reported previously (20) . Isolated islets were cultured overnight in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA) containing 2.8 mmol/L glucose, 2% fetal bovine serum, and penicillin/streptomycin/neomycin (50 U, 50 mg, and 100 mg, respectively; Sigma-Aldrich, St. Louis, MO) in humidity chambers filled with 95% O 2 and 5% CO 2 at 37°C.
RNA sequencing analysis
Islets were handpicked and frozen for RNA extraction with RNeasy Microprep (Qiagen, Hilden, Germany) from four NE-infused and four vehicle-infused control fetuses (20) . RNA samples (RNA integrity number $7) were submitted to University of Arizona Genetics Core for high-throughput sequencing as reported (25) . Double-stranded cDNA libraries from islet mRNA were constructed with the Illumina TruSeq RNA Sample Prep Kit (Illumina, San Diego, CA), according to manufacturer's instructions. Cluster generation was conducted with Illumina TruSeq 100-bp PE (Paired-End) Cluster Kit before running on the Illumina HiSeq2500 (four subjects per lane; two control and two IUGR). Adapter sequences were trimmed with Trimmomatic, and reads were assessed for quality with FASTQC (Babraham Bioinformatics, Babraham, England).
Transcriptome assembly and differential gene expression analysis was conducted with TopHat and Cufflinks programs (26) . Paired-end reads were aligned to the reference ovine (Ovis_aries.Oar_v3.1.74.toplevel.fa, ISGC, Ensembl release 74) with Bowtie2 (version 2.1.0) and TopHat (version 2.0.1) as described previously (25) . Read alignment parameters anchor length, anchor mismatch, intron length, mismatch, and read gap length were titrated to improve the overall read mapping rate and concordant pair mapping without inflating multiple alignments or discordant alignments. The TopHat parameters selected for the final analysis were anchor length 15, anchor mismatch 1, intron length 50000, mismatch 3, read gap length 4, -read edit distance 7, and -read realign edit distance 0, with all other parameters based on the TopHat default values. These alignment parameters produced a range of 24 to 39 million aligned pairs per sample, with 74% to 85% concordant alignments. Cufflinks (version 2.1.1) was used to assemble the aligned reads into transcripts based on Ensembl Ovis Aries release 74 annotation (26) . Genes were normalized according to Cufflinks protocol, and gene expression is presented as fragments per kilobase exon per million reads mapped (FPKM). Differential gene expression was determined with CuffDiff and visualized with the Bioconductor package CummeRbund. There was no manual curation of the gene list based on FPKM cutoffs. Differentially expressed genes in islets isolated from the NE fetuses compared with vehicle-infused control fetuses were annotated with multiple identifiers and Ensembl genome repositories (27) . This list of differentially expressed genes is referred to as NE-regulated genes.
Gene ontology terms and canonical pathways for differentially expressed genes were identified with KOBAS (version 3.0) (28) . Functional terms were significantly enriched if P , 0.05 following a Fisher exact test with Benjamini-Hochberg correction.
To summarize gene ontology enrichment and reduce redundant terms, genes were analyzed with ReviGO (29, 30) .
Comparative differential gene expression NE-regulated genes were compared with the previously published list of differentially expressed genes identified in islets from fetuses with PI-IUGR via the same RNA sequencing (RNAseq) analysis platform, accessible through the Gene Expression Omnibus GSE90022 (25) . The primary analysis was to obtain differentially expressed genes between experimental groups and their respective controls. Genes found on both lists were evaluated further and are referred to here as NE-regulated IUGR genes. For both experimental cohorts, singleton fetuses of the same breed were analyzed, which included males and females. Gestational age did not differ within experiments. Fetuses from the NE experiment were 139 6 1 days gestational age, and fetuses from the PI-IUGR experiment were 135 6 2 days gestational age at necropsy (20, 25) .
Chronic adrenergic receptor stimulation of Min6 cells
We obtained Min6 originally developed by Dr. Jun-ichi Miyazaki at Osaka University, Suita-shi, Japan (31, 32) . Min6 cells were routinely passaged (1:3) in RPMI 1640 medium containing 11.1 mmol/L glucose and 2 mmol/L glutamine and fortified with 10 mmol/L HEPES, 1 mmol/L sodium pyruvate, 10% fetal bovine serum (Atlas Biologicals, Fort Collins, CO), and 1% penicillin/streptomycin (Sigma-Aldrich). Cells were cultured at 37°C with 5% CO 2 . Experiments were conducted on cells between passage 30 and 35. To be included in the study, each passage of Min6 cells was required to have a normal morphology, have a consistent ratio of confluency (%) to absolute cell count, and secrete insulin at physiological glucose concentration.
Min6 cells were plated (500,000 cells per well) in six-well cultures plates and allowed to adhere and grow for 1 day. Cells were then cultured with medium supplemented without (control) or with (treatment) epinephrine (100 nmol/L; Vedco, Saint Joseph, MO). The concentration of epinephrine to maximally inhibit insulin secretion is 100 nmol/L and was determined previously (33) . Culture medium was replaced every 24 hours. After 72 hours, epinephrine was removed, and the cells were washed thoroughly. For each experiment (n $ 3) performed on different days, three independent wells for both control and treatment cultures were collected for RNA extraction (Qiagen). Additional wells were used to evaluate insulin secretion responsiveness, total insulin content, adrenergic desensitization, and cell density. Min6 cells were exposed to increasing concentrations of epinephrine (0.1 pM to 300 nM) after treatment, and insulin secretion was measured. Desensitization was determined by comparing the IC50 of epinephrine in treated and control Min6 cells. The number of cells was determined with a hemacytometer after enzymatic liberation, and absolute DNA concentrations were measured with Quant-iT Picogreen dsDNA (Thermo Fisher Scientific). Briefly, insulin secretion was conducted in Min6 cells incubated with 0 mM, 1 mM, or 20 mM glucose-supplemented Krebs-Ringer bicarbonate. After 1 hour, 500 mL incubation buffer was collected, frozen, and stored at 280°C until insulin concentrations were measured in duplicate by ELISA mouse insulin assay, and the interassay coefficient of variation was 9% 6 0.7% (ALPCO Diagnostics, Windham, NH). Cellular insulin contents were extracted from lysed cells in cold acid extraction (1 M HCl/70% ethanol), sonicated for 3 minutes, and incubated at 220°C overnight. Insulin concentrations were measured with a mouse insulin ELISA.
To verify that 72-hour epinephrine stimulation achieved adrenergic receptor desensitization, Min6 cells were exposed to increasing concentrations of epinephrine (0.1 pM to 300 nM) after treatment, and insulin secretion was measured. Desensitization was determined by comparing the IC50 of epinephrine in treated and control Min6 cells. Furthermore, ADRa2A protein concentration was determined with immunoblot. Briefly, Min6 cells were homogenized in cold lysis buffer containing 1% Nonidet P40, 150 mM NaCl, 1 mM EDTA, 1 mM Na 3 VO 4 , 1 mM NaF, 50 mM Tris, pH 7.4, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 0.4 ng/mL aprotinin, and 6.3 mg/mL leupeptin. Protein lysates were centrifuged at 13,000g at 4°C for 10 minutes, and the supernatant was frozen and stored at 280°C. Protein concentrations were determined by bicinchoninic acid protein assay (Thermo Fisher Scientific). Proteins (20 mg) were separated by SDS-PAGE (10%) and electrophoretically transferred to a polyvinylidene fluoride membrane (Bio-Rad, Hercules, CA). Membranes were blocked in 5% nonfat milk in Tris-buffered saline (10 mM Tris-HCl, 150 mM NaCl, pH 8) with 0.05% Tween 20 at room temperature for 1 hour and then incubated with an rabbit anti-ADRa2A antibody (1:500; Sigma-Aldrich) (34). Immunocomplexes were detected with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (1: 20,000; Bio-Rad) (35) and detected with SuperSignal West Pico (Thermo Fisher Scientific). The sum of the density of the band in each lane was quantified with ImageJ version 1.41 (https:// imagej.net/ImageJ). Multiple exposure times were analyzed to avoid saturation. Protein from each treatment was analyzed in duplicate on the same gel.
Quantitative PCR for fetal sheep islets and Min6 cells
To validate RNAseq findings, fold changes from the RNAseq analysis were correlated with quantitative PCR (qPCR) results. Thirteen genes were measured with qPCR on an expanded cohort of islets isolated from NE fetuses (n = 6) and vehicle controls (n = 6) collected previously (20) . The 13 genes in the correlation included qPCR results from eight genes reported previously. Five new genes were selected from RNAseq based on dramatic fold change ($3). RNA extraction and reverse transcription for qPCR were described previously (23, 36) . Briefly, RNA was extracted with RNeasy (Qiagen) from .500 islets per animal or 500,000 Min6 cells per replicate. Purity and concentration were determined by absorbance measurements at 260-nm and 280-nm wavelengths with a NanoDrop ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE). Sheep islet RNA quality (RNA integrity number .7) was assessed with an Experion analyzer (Bio-Rad). RNA (1 mg per reaction) was reverse transcribed, in triplicate, into cDNA with Superscript III reverse transcription (Invitrogen, Carlsbad, CA). Synthetic oligonucleotide primer sequences are available upon request. Optimal annealing temperatures for primer sets were determined with PCR. For primers to sheep genes, specificity was confirmed with nucleotide sequencing of the cloned PCR product (pCR 2.1-TOPO vector; catalog no. K4510oo20; Thermo Fisher Scientific). Primer efficiencies and sensitivities were measured with serial cDNA dilutions. All primers had efficiency $85%, and threshold cycles were linear over six orders of magnitude. Relative expression of mRNA was determined with SYBR Green (Qiagen) in a CFX Connect Real-Time PCR Detection System (Bio-Rad). After an initial 15-minute denaturation incubation at 96°C, all reactions went through 45 cycles at 96°C (30 seconds), annealing temperature (30 seconds), and 72°C (10 seconds) extension and read. To ensure product homogeneity, a melt curve analysis was performed. All qPCR results were normalized to the reference gene, ribosomal protein s15.
Statistical analysis
For RNAseq, islets from three male fetuses and one female fetus were included in each group, but effects of sex were not evaluated because of the low numbers and because fetal sex was not a factor in previous islet studies (24, 37) . Correlation in fold change of gene expression between RNAseq and qPCR was determined with the Pearson correlation coefficient (Prism 7.0; GraphPad Software Inc., La Jolla, CA). qPCR results were calculated as fold changes with the 2 2DDCT method (38) . Means for the in vitro physiological assessments, qPCR results, and immunoblots were analyzed by one-way ANOVA via the general linear means procedure of SAS software (version 9.4; SAS Institute, Cary, NC), and differences were determined with a post hoc least significant difference test. Means (6SEM) are presented and visualized in Prism 7.0. Values were significant if P , 0.05.
Results
NE-regulated genes in the islet transcriptome
RNAseq analysis of islets isolated from NE fetuses identified 321 differentially expressed genes compared with islets isolated from control fetuses [ Fig. 1 ; GSE106440 (39) ]. There were 143 downregulated genes and 178 upregulated genes. Abundant NE-regulated genes (control FPKM .50) with the greatest upregulation in expression encoded secretory and regulatory proteins for islets [regenerating islet-specific protein (REG3A), somatostatin (SST), ghrelin (GHRL)]. Other upregulated genes were involved in neuronal processes such as GABA transporter SLC32A1, SLITRK5, and syncollin (SYCN; Fig. 2) . NE-regulated genes (NE FPKM .50) with the greatest downregulation in expression compared with control values were involved in diverse processes that include genes associated with cell proliferation: MX dynamin-like GTPase 2 (MX2), histone cluster 1 H1 family member D (HIST1H1D), and downstream effector of Wnt signaling called ras homolog family member U (RHOU). Transglutaminase 2 (TGM2) and retinoic acid receptor responder 1 (RARRES1) were downregulated genes associated with retinoic acid signaling.
The fold changes for 13 genes were measured with qPCR and correlated (P , 0.001, R 2 = 0.83) positively with fold changes for these genes in the RNAseq results (Fig. 3) . The significant correlation between these independent methods of mRNA expression analysis provides validation for gene expression estimated by RNAseq.
Significantly enriched pathways for NE-regulated genes were secretory, metabolic, and cell connectivity pathways. The 10 most significantly enriched pathways are presented in Table 1 . Differentially expressed genes that may influence insulin secretion in b-cells include upregulation of glycolytic genes aldolase B (ALDOB; 2.2-fold) and fructose-1,6-bisphosphatase (FBP; 1.7-fold), as well as NK6 homeobox 3 (NKX6-3; 2.8-fold), phosphatase 2A inhibitor (PP2A; 2.5-fold), amino acid transporter SLC32A1 (10.2-fold), and ion transporters sodium-glucose transporter SLC5A2 (1.6-fold), inward-rectifying potassium channel KCNJ8 (3.2-fold), and sodium/potassium ATPase FXYD domain containing ion transport regulator 2 (FXYD2) (3.8-fold).
Identification of NE-regulated IUGR genes and functions
NE-regulated genes were compared with the 1065 genes identified previously in islets from sheep fetuses with PI-IUGR (25) . Ninety-six genes were differentially expressed in both models, yet eight were novel protein coding genes or pseudogenes. Genes with known function are presented in Table 2 with fold changes from each experiment, where the fold change is relative to each respective experimental control group. Pathways significantly enriched for NE-regulated IUGR genes were associated with pancreatic function, protein traffic, and metabolism of vitamins (Table 3) . A large proportion of the NE-regulated IUGR genes were associated with cell division, growth, and proliferation (Table 2 ) and included REG3A, TIMP metallopeptidase inhibitor 1 (TIMP1), and nuclear protein 1 transcriptional regulator (NUPR1).
Thirty-eight of the 96 NE-regulated IUGR genes (40%) responded in the same direction in both models with high fetal plasma catecholamines (Table 2 ). These 38 genes represent the potential adrenergic-specific component in the transcriptome of islets from fetuses with PI-IUGR. Functions for the 38 genes shifted to predominantly regulation of cell cycle components, M phase, and metabolic functions. Metabolic redox genes were downregulated and include GSR.
Chronic epinephrine treatment of Min6 cells recapitulates islet responses to norepinephrine
Min6 cells treated with 100 nM epinephrine for 72 hours had greater (n = 6, P , 0.05) glucose-stimulated insulin release compared with control cells (95.0 6 4.6 ng/h/10 5 cells vs 47.2 6 1.3 ng/h/10 5 cells, respectively; Fig. 4A ), but there was no difference in total insulin content (Fig. 4B) . In the presence of stimulatory glucose concentrations, an epinephrine dose-response curve was determined (Fig. 4C) , revealing that higher concentrations of epinephrine were needed to inhibit insulin secretion in Min6 cells treated with epinephrine than in controls. The IC50 for epinephrine was greater (P , 0.01) in Min6 cells treated with epinephrine for 72 hours than in control cells (Fig. 4D) , and ADRa2A concentrations were 69% lower in epinephrine-treated Min6 cells than in control cells (Fig. 4E ). There were fewer Min6 cells in epinephrine-treated wells (Fig. 5A and 5B) than in control wells and no difference in cell viability (Fig. 5C) .
From the 38 genes with the same directional change in islets from NE and PI-IUGR fetuses, we selected a subset of genes that regulate cell replication and evaluated their expression in Min6 cells that normally proliferate in culture. Four genes were evaluated in Min6 cells after a 72-hour epinephrine culture. Aurora kinase B (AURKB), (Fig. 5D ). MX2 was expressed in Min6 cells but was not different between treatments. These differences in proliferative gene expression were consistent with the reduced (P , 0.05) Min6 cell numbers after being cultured in epinephrine for 72 hours compared with control cultures (Fig. 5A and 5B).
Discussion
The experimental results identified transcriptome-wide changes in fetal sheep islets after persistent elevation of plasma NE concentrations that corroborate known physiological adaptations and identify new targets for adrenergic receptor programming of fetal islets. Seven days of high plasma NE concentrations altered the expression of genes involved in metabolism, protein traffic, and secretory functions in isolated and cultured islets. The overnight culture without NE identifies the persistent molecular signature of islets that exhibit hypersecretion of insulin reported previously in this model (20, 21) . We identified NE-regulated IUGR genes by comparing RNAseq results for islets from NE fetuses and fetuses with PI-IUGR. The 96 differentially expressed transcripts represent a small portion (9%) of the genes identified in PI-IUGR islets but were largely associated with proliferation and growth, implicating a role for adrenergic receptor regulation of b-cell mass. A subset of NEregulated IUGR genes involved in proliferation were responsive to chronic adrenergic receptor stimulation in Min6 cells that further implicates these genes in regulation of b-cell mass. The identification of differentially expressed genes associated with metabolism in islets from NE fetuses could explain enhanced GSIS that is independent from hyperglycemia and is linked to adrenergic receptor signaling. Previous work on NE fetuses showed that hypersecretion of insulin is a functional adaptation in islets that persisted for $5 days after termination of the NE infusion (20, 21) . Greater insulin secretion is linked to tighter metabolic coupling of glucose metabolism to the production of ATP, and our transcriptome analysis revealed 43 genes linked to cell metabolism, including greater expression of ion transporters and glycolytic genes. For example, inward-rectifying potassium channels, such as KCNJ8, allow potassium influx during resting states, which would lower the threshold for membrane depolarization and more readily activate voltage-gated calcium channels to stimulate insulin secretion. Ion transporters augment the sensitivity of stimulus-secretion coupling in b-cells because chloride and potassium flux across the plasma membrane increases (40, 41) . Genes encoding sodium and chloride membrane transporters were differentially expressed in NE fetal islets. Specifically, expression of FXYD2 and sodium dependent glucose transporter (SLC5A1) were increased. FXYD2 encodes a subunit of the sodium pump of Na,K-ATPase that is abundant in b-cells (42). Higher expression of metabolic genes could be attributed to the hyperglycemia seen in these NE fetuses, such as ALDOB, which is present in islets, and its abundance changes in response to hyperglycemia or hypoxia (20, 43) . However, hyperglycemia-mediated transcriptional control does not explain increased GSIS in islets isolated from fetuses with IUGR with hypoglycemia or from NE-infused fetuses with euglycemic correction (21, 23) . The 10 most significant pathways are presented in order of ascending P value after Benjamini-Hochberg multiple testing correction. The experimental gene quantity and total database quantity are the numbers of differentially expressed genes in NE-infused islets that are also annotated to the pathway. Pathways were identified by the online tool KOBAS (version 3.0) with online databases KEGG and Reactome. Genes that encode metabolic proteins involved in GSIS that are also linked to adrenergic receptor signaling were identified in the 321 NE-regulated genes. Mechanisms previously associated with a2-adrenergic receptor signaling include inward-rectifying potassium channels such as KCNJ8 to influence membrane potential (44), cAMP-regulated proteins such as PPP1R1A (an inhibitory subunit of protein phosphatase 1, increased in NE islets), cytokeratins (KRT1, KRT7, KRT8, KRT18, KRT78, and KRT80, increased in NE islets), proteases (45, 46) , and insulin exocytosis machinery (47, 48) . These findings identified differentially expressed metabolic genes linked to sustained adrenergic receptor stimulation in islets from NE fetuses that are distinct from the confounding effects of hyperglycemia and together may contribute to the observed persistent insulin hypersecretion. The 96 genes that overlapped are significantly enriched for presented pathways in order from corrected P value after Benjamini-Hochberg multiple testing correction. The experimental gene quantity and total database quantity are the numbers of NE-IUGR overlap genes and the total number annotated in a pathway, respectively. Most genes (84%) were identified by the online tool KOBAS and included in functional enrichment.
We compared islet gene expression between NE fetuses and fetuses with PI-IUGR to define NE-regulated IUGR genes because chronic elevation of plasma NE concentrations is an important component of PI-IUGR (13) . The 96 NE-regulated IUGR genes were associated with similar pathways as the NE-regulated gene list (Tables 1 and 3) , including secretion and metabolism of vitamins and cofactors. However, the majority of these genes did not change in the same direction relative to their respective controls in the two animal models. Some deviations were expected between the NE fetuses and fetuses with PI-IUGR, given the additional complications of nutrient and oxygen deprivation in the fetus with PI-IUGR. However, functional analysis of genes that changed in the same direction (38 total) in the NE-regulated IUGR gene list designated unique pathways of cell cycle and growth. In animal models of IUGR, endocrine cell mass is reduced, but there were no differences in endocrine mass for NE fetuses (20, 49) . It has been shown that high catecholamines in the sheep fetus contribute to asymmetric organ sparing during fetal growth restriction, but lowering catecholamines did not alleviate reductions in endocrine cell mass relative to other pancreatic cell types in fetuses with PI-IUGR (50, 51) . These findings indicate that elevated catecholamines alone represent a small fraction of genes altered in PI-IUGR, but the common genes are functionally enriched for growth and proliferation. Therefore, the overlapping genes capture changes associated with growth and proliferation before measurable loss of b-cell mass in NE fetuses (22, 23) .
To extend our findings on wholeislet RNAseq analysis, we evaluated candidate genes in vitro in a proliferating insulinoma cell line after chronic adrenergic receptor stimulation. In Min6 cells, chronic adrenergic receptor stimulation with epinephrine for 72 hours resulted in insulin hypersecretion and adrenergic desensitization, which are adaptations observed in islets from NE fetuses and fetuses with PI-IUGR (20, 23) . Furthermore, 72 hours of adrenergic receptor stimulation recapitulated observations in PI-IUGR islets including fewer cells and higher fractional insulin release. AURKB and CHD5 mRNA concentrations were decreased in Min6 cells after epinephrine treatment and in islet RNAseq data from both animal models. AURKB is involved with chromosome segregation, and its expression is highest during the transition from G2 to M phase in the cell cycle (52) . CHD5 encodes a chromatin-remodeling protein that modifies histones to alter transcription of genes, many associated with neuronal tissues (53) . Whereas neuronal tissue specificity can be explained in islets because of their heterogeneity and the potential for nerve density to alter transcript abundance, the lower gene expression in Min6 suggests chromodomain helicase DNA binding proteins as a potential epigenetic regulator of b-cell function.
DAPL1 expression was decreased in epinephrinetreated Min6 cells but increased in islets from NE fetuses and fetuses with PI-IUGR. The induction of DAPL1 in islets from fetuses with PI-IUGR was 10 times higher than in islets from NE fetuses, which indicates that DAPL1 was further upregulated by hypoxia or hypoglycemia. No studies have investigated the role of DAPL1 in islets, yet there is evidence that DAPL1 is present in the human pancreas (54) . The ancestral and larger family of DAP proteins have been associated with early epithelial differentiation, apoptosis through external stimulus such as interferon-g or TNFa, and facilitation of central death pathways (55) (56) (57) . Therefore, DAPL1 may be transcribed in naive epithelium, which would represent a limitation of RNAseq in heterogeneous cell populations such as islets. But it may also reflect disproportional growth restriction of endocrine cells relative to other cell types in PI-IUGR islets. A role for DAPL1 in apoptosis would also be consistent with decreased expression in epinephrine-treated Min6 cells that had slower rates of replication because there was no detectable increase in cell death. More studies are needed to define the specific role of DAPL1 in mature islets and b-cells.
Chronic exposure to elevated catecholamines caused insulin hypersecretion when they were inhibited (PI-IUGR) or when the infusion was discontinued (NE fetuses) in utero. Similar responses were shown for Min6 cells in vitro. Our primary objective was to define adrenergic-regulated mechanisms underlying the insulin hypersecretion in islets from both NE fetuses and fetuses with PI-IUGR by using comparative RNAseq. The underlying assumption was that changes in transcript abundance will result in similar changes in protein abundance and biological activity; however, we recognize that this is not true for all genes. In fact, this limitation was apparent, because the primary transcriptomic analysis did not reveal specific candidates to explain the insulin hypersecretion. These data indicate that posttranslational mechanisms regulating insulin hypersecretion follow chronic adrenergic stimulation. Posttranslational modifications are supported by clinical observations and current paradigms of fetal programming in the b-cell because neonates with IUGR have transient hyperinsulinemia (15, 16) .
One caveat to this experimental design was that insulin concentrations are lower in fetuses with PI-IUGR and NE fetuses. Therefore, the differential gene expression might reflect reductions in plasma insulin concentrations, which are similar between experimental groups (20, 25) . In primary mouse b-cells and Min6 cells, inhibited insulin activity slows proliferation (58, 59) . The Min6 cells treated with epinephrine for 72 hours also had slower proliferation rates, which could reflect lower insulin concentrations in these cultures or decreases in glucose metabolism and mitochondrial oxidative phosphorylation rates (33, 60) . Although the potential lack of activation of insulin receptors could explain the reduction in b-cell mass in fetuses with PI-IUGR, there was no reduction in NE fetuses or in chronically hypoglycemic fetuses with similar plasma insulin concentrations (61, 62) . However, the effect of low insulin concentrations on mRNA transcripts for growth and proliferation will need to be investigated to determine whether there is an interaction between adrenergic receptor stimulation and suppressed insulin concentrations. In Min6 cells chronic adrenergic stimulation resulted in fewer cells, adrenergic receptor desensitization, and higher fractional insulin release, which recapitulates the intrinsic islet response in fetuses with PI-IUGR and provides a model system to investigate the effects of chronic adrenergic activation.
In conclusion, the current study demonstrates metabolic gene changes in islets isolated from fetuses exposed to 7 days of chronically elevated catecholamines and establishes a cell model to further evaluate the role of chronic adrenergic receptor stimulation on insulin secretion. The uniquely robust comparative transcriptomic approaches on fetal islets exposed to NE identified proliferative genes that are dysregulated in PI-IUGR islets. These data establish adaptive responses that program proliferation in b-cells as a molecular component of adrenergic receptor signaling in PI-IUGR islets. Furthermore, the effects of chronic adrenergic signaling in Min6 cells in conjunction with previous findings that acute adrenergic stimulation reduces oxidative metabolism in Min6 cells poses new questions about the role of adrenergic receptor regulation of insulin secretion (33) . Whether adrenergic signaling is a dominant signal that causes dysregulation of b-cells independently of nutrient and oxygen availability is an important question with implications for treatment of fetuses with PI-IUGR.
